The idea that our more distressing emotions such as grief and anger can best be understood as symptoms of physical illnesses is pervasive and seductive.
Alcoholics Anonymous, the 80-year-old self-help program, has always had critics, who fault it for being too religious and unscientific. Journalist Gabrielle Glaser revives both these charges in her April Atlantic article, “The False Gospel of Alcoholics Anonymous.” She claims that “researchers have debunked central tenets of A.A.
This blog is the last in a series of guest posts on technology and the brain to celebrate Scientific American Mind’s 10-year anniversary.
This series uses the story of Dan Markingson's participation in a clinical trial of anti-psychotic drugs at the University of Minnesota, his suicide in 2004 while participating on the study, and subsequent events as a case study in which to explore various aspects of clinical trial conduct.
Targeting metacognition—our beliefs about thoughts—might alleviate mood disorders and even schizophrenia
How far is it from being to nothingness? I hope it's a journey you never decide to take, but wherever death by firearm is the most common method of suicide, it's about half an inch.
Dennis Hartman, a 47-year-old former business executive for an Illinois gaming company, described the diagnosis he had been given as “major depression disorder with severity of the extreme, social phobia and generalized anxiety disorder,” something he had lived with for more than 30 years.
There was an interesting array of topics at last week's Advancing Ethical Research conference sponsored by Public Responsibility in Medicine and Research (PRIMR), ranging from basics of Institutional Review Boards (IRB) to ethics of Ebola trials, which was excellent.
Psychiatric drugs have always been a black box. The complexity of the brain has meant that most successful drugs for treating disorders like depression, psychosis and bipolar disorder were discovered by accident and trial and error rather than rational design.
This research ethics series uses the story of Dan Markingson’s participation in a clinical trial of anti-psychotic drugs at the University of Minnesota, his suicide 2004 while participating on the study, and subsequent events as a case study in which to explore various aspects of clinical trial conduct.
Its all in your head, patients with unexplained pain or unexpected symptoms often hear. My recent post on rare diseases and pediatric pain clearly resonated with a number of people, prompting my immersion in the medical literature and speaking with some experts and patients about these topics and about the difficulties patients with atypical symptoms [...]
In 1990 The New York Times published a front-page article by Lawrence Altman, a reporter with a medical degree, announcing that scientists had discovered “a link between alcoholism and a specific gene.” That was merely one in a string of reports in which the Times and other major media hyped what turned out to be [...]
The scientific evidence is scant for many of the practice's widely touted benefits